Lifevantage Corporation
$ 4.13
-0.84%
14 Apr - close price
- Market Cap 53,396,000 USD
- Current Price $ 4.13
- High / Low $ 4.32 / 4.11
- Stock P/E 6.95
- Book Value 2.58
- EPS 0.60
- Next Earning Report 2026-05-05
- Dividend Per Share $0.18
- Dividend Yield 4.22 %
- Next Dividend Date -
- ROA 0.09 %
- ROE 0.25 %
- 52 Week High 14.70
- 52 Week Low 3.86
About
LifeVantage Corporation is dedicated to the identification, research, development and distribution of nutrigenomic activators, dietary supplements, nootropics, pre and probiotics, weight management, and skin and hair care products. The company is headquartered in Sandy, Utah.
Analyst Target Price
$8.00
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-02-03 | 2025-10-27 | 2025-09-04 | 2025-05-06 | 2025-02-05 | 2024-10-29 | 2024-08-28 | 2024-05-02 | 2024-01-30 | 2023-11-09 | 2023-08-28 | 2023-05-04 |
| Reported EPS | 0.15 | 0.18 | 0.17 | 0.26 | 0.22 | 0.15 | 0.14 | 0.21 | 0.1 | 0.13 | 0.17 | 0.08 |
| Estimated EPS | 0.1533 | 0.21 | 0.2 | 0.14 | 0.13 | 0.15 | 0.21 | 0.16 | 0.04 | 0.15 | 0.2 | 0.15 |
| Surprise | -0.0033 | -0.03 | -0.03 | 0.12 | 0.09 | 0 | -0.07 | 0.05 | 0.06 | -0.02 | -0.03 | -0.07 |
| Surprise Percentage | -2.1526% | -14.2857% | -15% | 85.7143% | 69.2308% | 0% | -33.3333% | 31.25% | 150% | -13.3333% | -15% | -46.6667% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-05 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | 0.16 |
| Currency | USD |
Previous Dividend Records
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2026-03-16 | 2025-12-15 | 2025-09-16 | 2025-06-13 | 2025-03-17 | 2024-12-16 | 2024-09-17 | 2024-06-14 | 2024-03-15 | 2023-12-15 |
| Amount | $0.045 | $0.045 | $0.045 | $0.045 | $0.04 | $0.04 | $0.04 | $0.04 | $0.035 | $0.035 |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: LFVN
2026-04-10 16:40:17
LifeVantage Corporation announced its participation in the Water Tower Research Insights Conference on April 15, 2026. CEO Steve Fife, CSHO Kristen Cunningham, and VP of R&D Lisa Barnes will represent the company. A webcast of the presentation will be available for all interested investors starting at 12:30 p.m. ET on the conference day.
2026-04-10 05:40:51
LifeVantage Corporation announced its participation in the Water Tower Research Insights Conference on Wednesday, April 15, 2026. Steve Fife (President and CEO), Kristen Cunningham (Chief Sales Officer), and Lisa Barnes (VP of Research & Development and Regulatory) will represent the health and wellness company at the event. The announcement was made on April 9, 2026.
2026-04-09 19:39:56
LifeVantage Corporation announced that its President and CEO, Steve Fife, Chief Sales Officer, Kristen Cunningham, and VP of Research & Development and Regulatory, Lisa Barnes, will participate in the Water Tower Research Insights Conference on April 15, 2026. The presentation will be webcast live at 12:30 p.m. Eastern Time and is open to all investors, with registration available through the company's investor relations website. LifeVantage, a nutrigenomics company, develops products aimed at optimizing health processes at the cellular level.
2026-04-09 19:39:56
LifeVantage (Nasdaq: LFVN) announced that its CEO Steve Fife, Chief Sales Officer Kristen Cunningham, and VP R&D Lisa Barnes will participate in the Water Tower Research Insights Conference on Wednesday, April 15, 2026. The webcast will begin at approximately 12:30 p.m. ET and is open access for all investors, who can register through the company's investor relations website. The executives will discuss corporate updates and R&D perspectives during their presentation.
2026-04-07 09:11:02
Lifevantage Corporation's (NASDAQ:LFVN) stock has fallen below its 200-day moving average, closing at $4.18, a bearish signal. This development has raised concerns among investors about the company's long-term trend. Analysts, however, have mixed ratings, with some setting price targets and others maintaining hold or buy ratings, indicating uncertainty about its future performance.
2026-04-04 01:40:12
Lifevantage Corp's CFO, Aure Carl, transferred 1,527 shares of common stock at $4.20 per share on April 1, 2026, to cover tax obligations. This transaction was labeled as a tax-withholding disposition rather than an open-market sale, and it leaves Carl with 156,915 directly held shares. The event, detailed in a Form 4 SEC filing, is categorized as a neutral impact on the stock as it relates to compensation administration rather than an active trading decision.
